Bill and Melinda Gates Foundation donations made to Colorado State University

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country
Facebook page coloradostateuniversity
Websitehttp://www.colostate.edu/
Twitter usernamecoloradostateu
Wikipedia pagehttps://en.wikipedia.org/wiki/Colorado_State_University
Instagram usernamecoloradostateuniversity

Full donee page for donee Colorado State University

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 45 121,021 428,952 -2,800 -176 -91 21,120 100,000 121,021 206,422 593,628 679,634 1,173,007 2,599,996
Global health 44 121,021 436,428 -2,800 -176 -91 21,120 100,000 121,021 208,591 593,628 862,470 1,173,007 2,599,996
Nutrition 1 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
Global health (filter this donor) 44 19,202,819.21 1,930,487.00 120,640.38 -526.31 2,810,641.74 2,155,224.00 1,456,098.00 1,200,758.59 3,478,903.81 100,000.00 900,451.00 1,348,384.00 3,701,757.00
Nutrition (filter this donor) 1 100,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 100,000.00 0.00 0.00 0.00
Total 45 19,302,819.21 1,930,487.00 120,640.38 -526.31 2,810,641.74 2,155,224.00 1,456,098.00 1,200,758.59 3,478,903.81 200,000.00 900,451.00 1,348,384.00 3,701,757.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (45 donations)

Amount (current USD)Amount rank (out of 45)Donation dateCause areaURLInfluencerNotes
1,768,326.0032018-10-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
162,161.00212018-08-23Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to promote the development of new antibiotics for the treatment of tuberculosis and other mycobacterial diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
121,021.00232017-10-09Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to promote the development of new antibiotics for the treatment of tuberculosis and other mycobacterial diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-85.58362017-08-11Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
-91.38372017-01-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-27.56342017-01-25Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-176.10412017-01-06Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-157.01392016-07-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-157.01392016-07-25Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-152.08382016-04-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-60.21352016-02-25Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,320,307.0022015-10-16Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
100,000.00242015-10-09Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to block residual malaria transmission by vaccinating cattle with selected, essential antigens from the mosquito Anopheles so that they produce antibodies that are lethal to the mosquitoes that feed on them.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
44,000.00312015-10-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-5.26332015-09-28Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
137,749.00222015-06-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
208,591.00182015-03-24Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to enable the discovery and development of more effective drug regimens for drug sensitive and drug resistant tuberculosis (TB) disease; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
50,000.00292014-10-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
50,000.00292014-10-06Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to reduce the incidence of malaria, lymphatic filariasis and soil transmitted helminth infections in Burkina Faso by administering the anti-parasitic drug ivermectin and insecticide treated nets during the dry-to-rainy seasonal transition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
678,939.00112014-07-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
540,187.00162014-04-28Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
591,185.00152014-04-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
244,913.00172014-02-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop methods to detect specific volatile organic compound (VOCs) signatures in Mycobacterium tuberculosis infected guinea pigs; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
862,470.0092013-07-29Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to determine the ability of high transmission strains of tuberculosis to grow in the relevant guinea pig small animal model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
593,628.00142013-02-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to facilitate a guinea pig natural transmission study, further the development of this natural transmission model, and establish cell based assays to detect M. tuberculosis infection regardless of vaccination status; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
206,422.00192012-10-29Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,000,000.0082012-05-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to test the effects of dietary rice bran and rice varietal differences in bacterial and viral pathogen disease prevention models; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-2,678.00442012-01-27Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-2,800.00452012-01-10Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-185.41422012-01-03Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,005,773.0072011-10-31Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate the metabolic status of host granulomatous tissue and TB during drug treatment and disease relapse in the mouse model of TB and during disease progression in the mouse and non-human primate models of TB; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,173,007.0052011-10-24Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a new mouse model resembling human pathology for TB drug development. Evaluation of a new murine model for testing tuberculosis chemotherapy. Investment start date: 10/24/2011 to end date: 10/31/2016. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
600,597.00122011-10-17Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to validate a novel approach and series of biomarkers for the diagnosis of tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
679,634.00102011-10-17Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop a robust, inexpensive, facile point-of-care test for accurate diagnosis of tuberculosis for use in high burden, low-income countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
21,120.00322011-07-13Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support a discussion of what can be learned from the successes and failures of BCG and how this can be applied to the development of more effective vaccines against TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-1,227.19432011-04-07Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara.
100,000.00242010-04-05Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to screen a diverse, global set of rice varieties to identify bioactive components in the bran that augment mucosal immunity against enteric bacterial pathogens; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.00242010-04-02Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to develop non-invasive phage particle based sensors for active tuberculosis. Non-Invasive Phage Particle Based Sensors for Active TB. Investment start date: 5/1/2010 to end date: 10/31/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
600,009.00132009-09-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
200,442.00202009-09-08Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.00242009-02-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a novel arthropod-based vaccine system against leishmaniasis. Novel arthropod-based vaccine system against leishmaniasis.. Investment start date: 5/1/2009 to end date: 10/31/2010. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.00242008-10-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to research whether providing endectocides, drugs that kill parasitic worms, to animals and humans will effectively kill mosquitoes which feed on them; Aid type: Project-type interventions. Affected regions: South of Sahara.
1,248,384.0042008-08-01Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to study the basis of why a small number of tuberculosis bacteria still persist in vivo after drug therapy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,101,761.0062007-09-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to provide standardized models for Tuberculosis drug discovery. TB Assay Standardization. Investment start date: 10/1/2007 to end date: 9/30/2011. Grantee name: Colorado State University; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,599,996.0012007-09-12Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to define the in vivo physiology of Mycobacterium tuberculosis and implement methods to asses metabolites found in M. tuberculosis infected tissue; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.